PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024. More detail to come.Additional information on Diabetes New Zealand website and the Pharmac Websites
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
Recombinant Human t-Plasminogen Activator (t-PA) (carrier-free), 10 μg
Recombinant Human t-Plasminogen Activator (t-PA) (carrier-free), 25 μg
Recombinant Human TPO (carrier-free), 10 µg
Recombinant Human TPO (carrier-free), 100 µg
Recombinant Human TPO (carrier-free), 25 µg
Recombinant Human TRAIL (TNFSF10) (carrier-free), 10 μg
Recombinant Human TRAIL (TNFSF10) (carrier-free), 100 μg
Recombinant Human TRAIL (TNFSF10) (carrier-free), 25 μg
Recombinant Human TRANCE (RANKL) (Animal-Free), 10 μg
Recombinant Human TRANCE (RANKL) (carrier-free), 10 μg
Recombinant Human TRANCE (RANKL) (carrier-free), 100 μg
Recombinant Human TRANCE (RANKL) (carrier-free), 25 μg
Recombinant Human TRANCE (RANKL) (carrier-free), 500 μg
Recombinant Human TSLP (carrier-free), 10 μg
Recombinant Human TSLP (carrier-free), 100 μg
Recombinant Human TSLP (carrier-free), 25 μg